Country Information


Malawi

 
HIV prevalence 15-49, 2007/2008 11.9%
Tuberculosis death rate 97/100,000 population
Malaria death rate (children under 5) 1,288/100,000 population
 
   
             
     
  Malawi, a country of 12 million located in south-central Africa, faces a substantial health crisis due to an AIDS epidemic and a considerable increase in the prevalence of TB. Between 1985 and 1999 TB cases shot up from 5,000 to 25,000. According to the Panafrican News Agency, 25 Malawians are now dying of TB every day. Multi-drug resistant TB (MDRTB) has recently developed as a result of improper use of TB drugs. Malawi has instituted 100 percent DOTS coverage, and the national TB treatment success rate is 70.8 percent.

AIDS has increased Malawi’s crude death rate by 44 percent between 1990-2000,with a corresponding drop in life expectancy. In some urban areas of the country 30 percent of pregnant women are HIV positive, and 15 percent of all Malawian adults test positive for HIV. Four years ago there were already 270,000 AIDS orphans in the country. At least ten percent of the urban work force is expected to die of AIDS in the next ten years, further damaging a weak economy. In order to reduce mother-to-child-transmission of HIV, hospitals in Malawi are now delivering 10-12 percent of all babies by caesarian section.

Malawi has recently announced the release of its first national HIV/AIDS Policy. The new HIV/AIDS Policy includes guidance on prevention, and care and support of infected persons, as well as addresses human rights that are important for combating HIV/AIDS, such as a woman’s right to protection against marital rape.

Malaria is endemic in Malawi, and is the cause of 40 percent of deaths among Malawian children under 2. According to Population Services International, "Children under five suffer on average 9.7 malaria episodes per year, while adults suffer 6.1 such episodes."

Per capita Gross National Income (GNI) in Malawi is currently estimated to amount to around $160 annually. In 2000 population growth exceeded growth in GDP, further impoverishing the country. According to the International Monetary Fund, income distribution in Malawi is the most unequal in all of Africa; two thirds of Malawians live on an annual income of $40 or less. As a result, while at least 800,000 Malawians are living with HIV/AIDS, only a handful of patients in the country can afford expensive treatments such as triple-drug anti-retroviral therapy.

Sources: U.S. Agency for International Development (USAID), Panafrican News Agency, CIA Factbook, Medicins Sans Frontieres, University of Strathclyde Malawi Millennium Project, World Health Organization, Synergy Project; USAID

 
           
             
  The stated objectives of Malawi's National Health Plan for 1999-2004 include achievement of the following:
  • Expanding the range and quality of health services for mothers children under the age of 5 years.
  • Providing better quality health care in all facilities.
  • Strengthening, expanding and integrating health services to the general population.
  • Increasing efficiency and equity in resource allocation.
  • Increasing access to health care facilities and basic services.
  • Increasing the quality of trained human resources increased, and improving the equality and efficiency of their distribution.
  • Strengthening collaboration and partnership in health sector.
  • Increasing the overall resources in the health sector.

In response to the development of drug resistance in malaria, Malawi was one of the first African nations to shift from the use of chloroquine to the use of sulphadoxine-pyramethamine. Malawi's Ministry of Health and Population (Community Health Sciences Unit) continues to study optimal drug policies to slow down the evolution of drug resistant parasites; collaborating institutions include the University of Malawi and the Wellcome Trust (UK). In late 2002 Malawi adopted Dafra Pharma's drug Arinate as a key part of its $29 million anti-malarial campaign.

Sources: Ministry of Health and Population home page, Beattie, Renshaw and Davies (1999), Multilateral Initiative on Malaria

 
           
             
 
Total population. mid-2009 14.2 (millions)
HIV prevalence 15-49, 2007/2008 11.9%
Tuberculosis death rate 97/100,000 population
Prevalence of tuberculosis per 100,000 population, 2000 539
Prevalence of tuberculosis per 100,000 population, 2004 501
% Tuberculosis detection rate under DOTS, 2001 41
% Tuberculosis detection rate under DOTS, 2004 40
% Tuberculosis treatment success rate under DOTS, 2000 73
% Tuberculosis treatment success rate under DOTS, 2003 74
Malaria death rate (children under 5) 1,288/100,000 population
GNI PPP Per Capita, 2008 830 (US$)
Life expectancy at birth 46 years
Infant mortality rate 80/1,000 live births
Total fertility rate 6.3 per woman
Crude birth rate 43/1,000 population
Crude death rate 12/1,000 population
Adult male literacy level 82% (pct. 15+ literate)
Adult female literacy level 71% (pct. 15+ literate)
Contraceptive prevalence rate, modern methods 39% of women in union
Estimated number of people living with HIV: Adults and Children, 2005 940,000
Estimated number of people living with HIV: Adults and children, end 2003 900,000
Estimated number of people living with HIV: Adults and children, end 2001 850,000
Estimated number of people living with HIV: Adults (15+), 2005 850,000
Estimated number of people living with HIV: Adults (15-49), end 2003 810,000
Estimated number of people living with HIV: Adults (15-49), end 2001 770,000
Estimated number of people living with HIV: Adults (15-49) rate (%), 2005 14.2%
Estimated number of people living with HIV: Adults (15-49) rate (%), 2003 14.3%
Estimated number of people living with HIV: Women (15+), 2005 500,000
Estimated number of people living with HIV: Women 15-49, end 2003 460,000
Estimated number of people living with HIV: Women 15-49, end 2001 440,000
Estimated number of people living with HIV: Children (0-14), 2005 91,000
Estimated number of people living with HIV: Children (0-14), end 2003 83,000
Estimated number of people living with HIV: Children (0-14), end 2001 77,000
Estimated number of AIDS deaths: Adults and children, 2005 78,000
AIDS deaths in adults and children, end 2003 84,000
AIDS deaths in adults and children, end 2001 75,000
Estimated number of orphans due to AIDS: Children (0-17), 2005 550,000
Orphans due to AIDS (0-17), living 2003 500,000
Orphans due to AIDS (0-17), living 2001 390,000
% Women (15-49), currently married or living with a partner, who have ever discussed AIDS prevention with their husband or partner 72%

Demographic data contained in this section was obtained from the following sources: The Population Reference Bureau’s 2009 World Population Data Sheet was used for total population, life expectancy at birth, infant mortality, fertility, birth rate, death rate, % of married women 15-49 using modern methods of contraception, % of population 15-49 with HIV/AIDS in 2007/2008, and the GNI PPP per capita (2008). Literacy rates were found in the Population Reference Bureau’s publication 2005 Women of Our World. HIV prevalence data for 2001 and 2003 was obtained from the UNAIDS Barcelona 2002 report; HIV prevalence and orphan data for 2005 was obtained from the UNAIDS Report on the Global AIDS Epidemic 2006. Data on the % women who have discussed AIDS prevention with their husband or partner can be found in ORC Macro and USAID’s Women’s Lives and Experiences: Changes in the Past Ten Years (Research Findings from the Demographic and Health Surveys). Childhood malaria mortality data was accessed in 2003 from the United Nations Statistics Divisions’ Millennium Indicators. Tuberculosis data was obtained from the United Nations Statistics Division’s Millennium Indicators: MDGInfo 2006. In some cases information was unavailable.

 
           
             
  Like many African nations, Malawi's national government has a three-tiered public health system, with 328 health centers providing basic health care, and more complicated treatment provided at 24 district hospitals. Difficult cases may be referred to one of Malawi’s four central hospitals: Lilongwe Central Hospital in the capital, Queen Elizabeth Central Hospital in Blantyre, Zomba Central Hospital in Zomba, and a fourth central hospital newly constructed in the northern city of Mzimba. The health infrastructure continues to be less well developed in the northern half of the country than in the south. Zomba Central Hospital was the site of a recent Johns Hopkins study that concluded that malnutrition contributed to in HIV+ patients with pulmonary TB.

The 64 bed Mwaiwathu Private Hospital in Blantyre provides some of the best medical treatment in the country, but is too expensive for all but the wealthiest businessmen and highest ranking government officials. The US Embassy has identified the Likuni Mission Hospital in Lilongwe as the best of the local hospitals.

The Christian Hospital Association of Malawi (CHAM) plays a critical role in augmenting the goverment's health system. Approximately 18 church-run hospitals and a larger number of clinics receive government financing to provide medical services for many parts of the country. In addition to medical services, CHAM provides medical training and education throughout Malawi.

Most of Malawi’s hospitals have TB wards, with a total of around 1,500 beds. A World Health Organization survey found that overcrowding in the central hospital TB wards had exceeded capacity by 64%, and patients without beds were given space on the floor. Fewer than half of the TB wards have full time nursing staff.

Sources: Malawi's Ministry of Health and Population; Bulletin of the World Health Organization, April 2001; Scottish Malawi Network, (Malawi Update, September 1998); Medecins Sans Frontieres

 
           
             
 

Malawi College of Medicine

The College of Medicine is a partner in the $40 million Gates Malaria Programme coordinated by the London School of Hygiene and Tropical Medicine.

The College of Medicine is also a member, in collaboration with Johns Hopkins University and the University of North Carolina, of HIVNET.

Ministry of Health, Malaria Control Programme

Malawi's Ministry of Health produced 18 scientific publications on malaria in the years 1995-1997; intervention trials and health services research are areas of special expertise.

Source: Beattie, Renshaw and Davies (1999)

National Tuberculosis Control Program, Community Health Sciences, Ministry of Health and Population

Anthony Harries of Malawi's National Tuberculosis Control Program has led or participated in several recent studies resulting in articles published in the International Journal of Tuberculosis and Lung Disease. These studies include:
  • A study of the management of TB cases at all 43 non-private (public and mission) hospitals in Malawi. PubMed abstract
  • A study of the operational research capacity of Malawi's network of hospital TB officers. PubMed abstract
  • A study of active TB case-finding in Malawi's Thyolo district, carried out in conjunction with Medecins sans Frontieres. The study concluded that greater use should be made of chest X-rays to diagnose TB in areas of TB/HIV coinfection; chest X-rays reduce mortality in such areas by identifying individuals likely to benefit from INH prophylaxis. PubMed abstract

Anthony Harries has suggested that anti-retroviral drug programs in Africa be modeled on and utilize much of the infrastructure of existing DOTS programs where that is possible. Source: Kaiser Daily HIV/AIDS Report, Aug-6-01

Dr. Felix Salaniponi of the TB Control Program is the PI on a Norwegian-funded study of MDR-TB in Malawi. Source: WHO MDR-TB Research Database

Severe Malaria in African Children (SMAC) site ( website )

Malawi is host to one of five centers in the SMAC clinical trials network.

Wellcome Trust Research Laboratories ( website )

The Wellcome Trust Research Laboratories, located at Queen Elizabeth Hospital in Blantyre, were opened in 1999 as a result of collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, the College of Medicine at the University of Malawi, and funding provided by the Wellcome Trust. Among other research projects, this laboratory has been involved in developing an anti-malarial drug to replace Fansidar.

 
           
             
 

Entity

Project Title

Diseases

Primary Category

Secondary Category

NIH Zidovudine at Birth to Reduce Perinatal HIV Transmission HIV/AIDS Drug Development Prevention
  (Principal Investigator: Taha Taha. 1999-2002.) This AIDS- FIRCA study investigated the efficacy of giving AZT to HIV-positive mothers during...

NIH Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS HIV/AIDS,Tuberculosis Drug Development  
  (PI: Richard Semba. 1998-2003.) The objective of this double-blind placebo- controlled study is to determine the efficacy of Vitamin A...

NIH Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BuffeGel and 0.5% PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women HIV/AIDS Drug Development  
  (Study Chair: Salim Abdool Karim). 3220 participants in Malawi, South Africa, Tanzania, and Zimbabwe will be enrolled in this study designed to...

NIH Preventing Sexual Transmission of HIV with Anti-HIV Drugs HIV/AIDS Drug Development  
  (Study Chair: Myron S. Cohen) This multi-site study will enrol a total of 3500 participants in Brazil, India, Malawi, Thailand, the U.S., and...

NIH Once-Daily PI/NNRTI Therapy Combination for Treatment Naive, HIV Infected Patients in Resource-Limited Conditions HIV/AIDS Drug Development  
  (Study Chairs: Thomas B. Campbell, Timothy Flanigan, James Hakim, Nagalingeswaran Kumarasamy) This is a randomized trail with an expected...

NIH Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies HIV/AIDS Drug Development Prevention
  (PIs: Mark Mirochnick, George Kafulafula, Regis Kreitchmann). This trial is designed to examine the safety and efficacy of Tenofovir Disoproxil...

NIH Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis HIV/AIDS,Tuberculosis Drug Development  
  National Institute of Allergy and Infectious Diseases (Study Chair: Diane Havlir). This trial has been carried out in 22 sites across 10...

NIH Clinical trial of chloroquine combinations in Malawi Malaria Drug Development  
  This study proposes to test the efficacy of chloroquine alone and in combination with other drugs that may prevent the reemergence of chloroquine...

NIH TS Prophylaxis and Drug-Resistant Malaria in Malawi Malaria Drug Development  
  (PI: Christopher Plowe. 2001-2004.) The study examines the benefits of TS Prophylaxis and tests the hypothesis that TS prophylaxis selects for...

NIH Gender, Conversational Networks and Dealing with STD's HIV/AIDS Epidemiology  
  (PI: Susan Watkins. 2001-2006.) Among the study's aims is the development of a longitudinal quantitative and qualitative public use data set for the...

NIH Malaria and HIV in Pregnant Women in Malawi HIV/AIDS,Malaria Epidemiology  
  (PI: Steven Meshnick. 2001-2006.) The study examines whether maternal malaria increases mother-to-child transmission (MTCT) of HIV in...

NIH Perceived AIDS Stigma: A Multinational African Study HIV/AIDS Epidemiology  
  (PI HOLZEMER, WILLIAM L. 2003-2008) This is a five-year collaboration project linking five country members (Lesotho, Malawi, South Africa,...

NIH Effect of Parasitic Infection on HIV Disease in Malawi HIV/AIDS Epidemiology  
  (PI: Mina Hosseinipour. 2003-2007.) The purpose of this study is to determine if parasitic infections, especially helminth infections, have any...

NIH AIDS/HIV Risk, Marriage and Sexual Relations in Malawi HIV/AIDS Epidemiology Prevention
  (PI: Hans-Peter Kohler. 2003-2007.) This is a study of social and sexual dynamics that contribute to or prevent the spread of HIV. Data collection...

NIH Drug-Resistant Malaria in Malawi Malaria Epidemiology  
  (PI: Christopher Plowe. 1999-2004.) A study of P. falciparum resistance to chloroquine and pyrimethamine-sulfadoxine.

NIH Mobilizing Health Workers for HIV HIV/AIDS Prevention Capacity
  (PI: Kathleen Norr. 2001-2006.) This project is meant to train health workers at district hospitals to engage in behavior changing...

NIH HIV Prevention Trials Unit - Malawi HIV/AIDS Prevention Drug Development
  (PI: Taha Taha. 2000-2005) The Malawi College of Medicine (COM), Johns Hopkins University (JHU) and the University of North Carolina (UNC) are...

NIH AIDS International Training and Research Program HIV/AIDS Capacity  
  (PI: Adaora Adimora. 1998-2003.) The objective of this grant is to improve the laboratory facilities at Lilongwe Central Hospital in order to...

NIH UIC-AITRP In Chile, Indonesia and Malawi HIV/AIDS Capacity  
  (PI: Judith Levy. 2000-2005.) Aids International Training Research Program (AITRP) aimed at building longterm scientific capacities to combat the...

NIH Building AIDS Research Through UIC AITRP in Malawi HIV/AIDS Capacity  
  (PI: Chrissie Kaponda. 2002-2007.) A grant to build capacity for HIV/AIDS research in Malawi.

NIH Training Medical School Faculty to Tackle Malaria in Malawi Malaria Capacity  
  (PI: Taylor Terrie. 1997-2003.) [no further information available]

NIH Infectious Disease Epidemiology Training for Malawians Malaria Capacity  
  (PI: Steven Meshnick. 2003-2008.) This grant funds a collaborative capacity-building partnership between the University of North Carolina and the...

NIH International Neurological Study: A Stand Alone Study for Participants of A5175 HIV/AIDS General Capacity
  (Study Chairs: Kevin Robertson, Johnstone Kumwenda, Khuanchai Supparatpinyo). This trial will include 960 participants already involved in the...

NIH Fluid Resuscitation in Pediatric Falciparum Malaria Complicated by Acidosis Malaria General  
  (PI: Stanley Usen. 2002) Children who die of malaria frequently die within 12 hours of hospital admittance, and swelling of the brain may be a cause...

Other US Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers HIV/AIDS Drug Development Prevention
  Centers for Disease Control (PIs: Sherry Farr, Denise Jamieson, Charles Van der Horst, Peter Kazembe). The investigators are examining the impact...

Other US Extended Infant Post-Exposure Prophylaxis with Antiretrovirals to Reduce Postnatal HIV Transmission HIV/AIDS Drug Development Prevention
  Johns Hopkins Bloomberg School of Public Health. (PIs: Taha E Taha, Newton I Kumwenda). 3500 infants were enrolled in this trial to examine...

Other US Combined Oral Contraceptive (COC) Antiretroviral (ARV) Pharmacokinetics (PK) and Pharmacodynamics (PD) in Malawi (COCARVPK) HIV/AIDS Drug Development  
  University of North Carolina, Chapel Hill (PI: Gretchen S. Stuart). This pilot study will enroll 9 women to determine the impact of antiretroviral...

Other US FEM-PrEP (Truvada®) Phase III Clinical Trial HIV/AIDS Drug Development Prevention
  Family Health International (Study Director: Jennifer Deese; PIs: Lut Van Damme, Amy Corneli). 3900 HIV-negative women in Kenya, Malawi,...

Other US Breastfeeding, Antiretroviral and Nutrition Study HIV/AIDS Prevention  
  CDC, UNC, and Kamuzu Central Hospital. (Study Chair: Charles van der Horst; PIs: Denise Jamieson, Peter Kazembe). 2418 pregnant HIV-positive...

Other US USAID HIV/AIDS,Tuberculosis,Malaria General  
  In its 2004 Congressional Budget Justification for Malawi,...

International An Expanded Safety Study of Dapivirine Gel 4759 in Africa HIV/AIDS Drug Development  
  International Partnership for Microbicides, Inc.(Study Director: Dr. Annalene Nel). 330 HIV-negative women between the ages of 18 and 40 will be...

International Europe-Africa Research Network for Evaluation of Second-Line Therapy (EARNEST) HIV/AIDS Drug Development General
  European and Developing Countries Clinical Trials Parntership; the University of Malawi; in Uganda, the Joint Clinical Research Centre, Infectious...

International DFID Tuberculosis Work Programme Tuberculosis Drug Development Epidemiology
  The DFID Tuberculosis Work Programme is funded by the United Kingdom's Department for International Development, and coordinated by the London...

International Phase II Artesunate Study in Severe Malaria Malaria Drug Development General
  Medicines for Malaria Venture, European Developing Country Clinical Trial Partnership, Severe Malaria in African Children Consortium (PI: Peter...

International Safe and Efficacious Artemisinin-Based Combination Treatments for African Pregnant Women with Malaria (PREGACT) Malaria Drug Development  
  Institute of Tropical Medicine, Belgium; Seattle Institute for Biomedical and Clinical Research; National Institute for Medical Research, Tanzania;...

International Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa Malaria Drug Development  
  GlaxoSmithKline will conduct this clinical trial at its investigational sites in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique, and...

International Norway (NORAD) Tuberculosis Epidemiology  
  NORAD is funding a study of MDR-TB being led by Dr. Felix Salaniponi of Malawi's National TB Control Program. No additional information is...

International European Union Tuberculosis Epidemiology  
  The European Union (INCO-DC) has funded the following study of TB in Malawi:
  • The natural history of environmental mycobacteria in Karonga
...

International CIDA (Canada) HIV/AIDS Prevention  
  In 2000 CIDA pledged $13 million (Canadian) over five years to support HIV/AIDS prevention programs in Malawi.

International Gestational Sulfadoxine-Pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth Malaria Prevention General
  University of Tampere, Academy of Finland, Foundation for Paediatric Research, Medical Research Fund of Tampere University Hospital (Study...

International LAM ELISA in Diagnostics of Childhood TB Tuberculosis Capacity Drug Development,Capacity
  University Hospital, Bonn; Our Lady of Mount Carmel Community Hospital; Ministry of Health and Population, Malawi; Mbeya Medical Research Programme,...

International UNAIDS HIV/AIDS General  
  The UNAIDS program in Malawi represents a collaborative effort including the World Health Organization...

International Global Fund for AIDS, Tuberculosis and Malaria (GFATM) HIV/AIDS,Malaria General  
  The Global Fund has selected Malawi as a primary battleground in the fight against AIDS tuberculosis and malaria. $41.7 million has approved to...

NGO International Red Cross and Red Crescent HIV/AIDS,Tuberculosis,Malaria General  
  The American Red Cross, Danish Red Cross, and Icelandic Red Cross all have operations in Malawi.

Source: International Federation of Red Cross...

NGO IUATLD Tuberculosis General  
  The International Union Against Tuberculosis and Lung Disease (IUATLD) has been providing technical support for Malawi's DOTS (directly...

Foundation Gates Foundation HIV/AIDS,Tuberculosis General  
  In 1999 the Bill and Melinda Gates Foundation pledged $1.9 million over five years to fight TB and other respiratory illnesses in Malawi. The...

Foundation Wellcome Trust Tuberculosis,Malaria General  
  Wellcome Trust is funding the following research by the London School of Hygiene and Tropical Medicine (LSHTM) in Malawi:
  • Epidemiology of
...

 
           
             
 
  1. The Global AIDS Program (GAP) of the CDC intends to significantly increase its involvement in Malawi's anti-AIDS program over the next several years, including:
    • Assisting the Malawi AIDS Counseling and Resource Organization (MACRO) in extending its voluntary counseling and testing (VCT) program throughout the country.
    • Supporting a pilot project for the prevention of HIV transmission to and through
    ... additional information

  1. The Global Fund has approved $20.9 million to fight malaria in Malawi. The grant agreement has not yet been signed.

    Source: Global Fund agreements and disbursements spreadsheet

 
           



Home || HIV/AIDS || Tuberculosis || Malaria || Advanced Search || Links || Contact Us

Last site update: November 19, 2009

For questions, or to report problems with this site, please contact the Webmaster.

Disclaimer